vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Smart Sand, Inc. (SND). Click either name above to swap in a different company.

Smart Sand, Inc. is the larger business by last-quarter revenue ($86.0M vs $83.1M, roughly 1.0× PROCEPT BioRobotics Corp). Smart Sand, Inc. runs the higher net margin — 1.4% vs -38.1%, a 39.4% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs -5.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 1.8%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Sand 9 is a fabless Micro-electromechanical system (MEMS) company based in Cambridge, Massachusetts. Sand 9 developed a piezoelectric MEMS resonator to serve as an alternative for quartz timing devices in applications such as smart phones, low-power wireless devices, and communications infrastructure equipment.

PRCT vs SND — Head-to-Head

Bigger by revenue
SND
SND
1.0× larger
SND
$86.0M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+26.0% gap
PRCT
20.2%
-5.8%
SND
Higher net margin
SND
SND
39.4% more per $
SND
1.4%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
1.8%
SND

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
SND
SND
Revenue
$83.1M
$86.0M
Net Profit
$-31.6M
$1.2M
Gross Margin
64.9%
13.0%
Operating Margin
-4.1%
-3.1%
Net Margin
-38.1%
1.4%
Revenue YoY
20.2%
-5.8%
Net Profit YoY
-27.9%
-68.5%
EPS (diluted)
$-0.56
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
SND
SND
Q1 26
$83.1M
Q4 25
$76.4M
$86.0M
Q3 25
$83.3M
$92.8M
Q2 25
$79.2M
$85.8M
Q1 25
$69.2M
$65.6M
Q4 24
$68.2M
$91.4M
Q3 24
$58.4M
$63.2M
Q2 24
$53.4M
$73.8M
Net Profit
PRCT
PRCT
SND
SND
Q1 26
$-31.6M
Q4 25
$-29.8M
$1.2M
Q3 25
$-21.4M
$3.0M
Q2 25
$-19.6M
$21.4M
Q1 25
$-24.7M
$-24.2M
Q4 24
$-18.9M
$3.7M
Q3 24
$-21.0M
$-98.0K
Q2 24
$-25.6M
$-430.0K
Gross Margin
PRCT
PRCT
SND
SND
Q1 26
64.9%
Q4 25
60.6%
13.0%
Q3 25
64.8%
16.1%
Q2 25
65.4%
10.4%
Q1 25
63.9%
4.2%
Q4 24
64.0%
14.7%
Q3 24
63.2%
10.3%
Q2 24
59.0%
17.7%
Operating Margin
PRCT
PRCT
SND
SND
Q1 26
-4.1%
Q4 25
-40.6%
-3.1%
Q3 25
-27.8%
5.8%
Q2 25
-28.0%
-0.1%
Q1 25
-39.7%
-10.8%
Q4 24
-28.9%
3.9%
Q3 24
-38.4%
-7.8%
Q2 24
-50.3%
4.8%
Net Margin
PRCT
PRCT
SND
SND
Q1 26
-38.1%
Q4 25
-39.1%
1.4%
Q3 25
-25.7%
3.2%
Q2 25
-24.7%
24.9%
Q1 25
-35.8%
-37.0%
Q4 24
-27.6%
4.1%
Q3 24
-35.9%
-0.2%
Q2 24
-48.0%
-0.6%
EPS (diluted)
PRCT
PRCT
SND
SND
Q1 26
$-0.56
Q4 25
$-0.54
$0.03
Q3 25
$-0.38
$0.08
Q2 25
$-0.35
$0.54
Q1 25
$-0.45
$-0.62
Q4 24
$-0.34
$0.10
Q3 24
$-0.40
$0.00
Q2 24
$-0.50
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
SND
SND
Cash + ST InvestmentsLiquidity on hand
$245.6M
$22.6M
Total DebtLower is stronger
$51.7M
$15.0M
Stockholders' EquityBook value
$347.7M
$239.7M
Total Assets
$487.1M
$340.0M
Debt / EquityLower = less leverage
0.15×
0.06×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
SND
SND
Q1 26
$245.6M
Q4 25
$286.5M
$22.6M
Q3 25
$294.3M
$5.1M
Q2 25
$302.7M
$4.3M
Q1 25
$316.2M
$5.1M
Q4 24
$333.7M
$1.6M
Q3 24
$196.8M
$7.2M
Q2 24
$214.1M
$6.3M
Total Debt
PRCT
PRCT
SND
SND
Q1 26
$51.7M
Q4 25
$51.6M
$15.0M
Q3 25
$51.6M
$14.3M
Q2 25
$51.5M
$23.5M
Q1 25
$51.5M
$13.7M
Q4 24
$51.5M
$14.7M
Q3 24
$51.4M
$15.7M
Q2 24
$51.4M
$17.1M
Stockholders' Equity
PRCT
PRCT
SND
SND
Q1 26
$347.7M
Q4 25
$365.9M
$239.7M
Q3 25
$380.3M
$239.9M
Q2 25
$385.8M
$240.5M
Q1 25
$389.2M
$219.9M
Q4 24
$402.2M
$243.8M
Q3 24
$241.2M
$243.6M
Q2 24
$251.8M
$242.9M
Total Assets
PRCT
PRCT
SND
SND
Q1 26
$487.1M
Q4 25
$508.1M
$340.0M
Q3 25
$511.5M
$343.1M
Q2 25
$513.1M
$345.8M
Q1 25
$519.4M
$326.9M
Q4 24
$534.0M
$341.5M
Q3 24
$374.1M
$335.8M
Q2 24
$374.4M
$341.8M
Debt / Equity
PRCT
PRCT
SND
SND
Q1 26
0.15×
Q4 25
0.14×
0.06×
Q3 25
0.14×
0.06×
Q2 25
0.13×
0.10×
Q1 25
0.13×
0.06×
Q4 24
0.13×
0.06×
Q3 24
0.21×
0.06×
Q2 24
0.20×
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
SND
SND
Operating Cash FlowLast quarter
$22.4M
Free Cash FlowOCF − Capex
$20.4M
FCF MarginFCF / Revenue
23.7%
Capex IntensityCapex / Revenue
2.3%
Cash ConversionOCF / Net Profit
18.99×
TTM Free Cash FlowTrailing 4 quarters
$32.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
SND
SND
Q1 26
Q4 25
$-10.3M
$22.4M
Q3 25
$-6.6M
$18.2M
Q2 25
$-15.0M
$-5.1M
Q1 25
$-17.0M
$8.7M
Q4 24
$-32.4M
$1.0M
Q3 24
$-18.8M
$5.8M
Q2 24
$-15.7M
$14.9M
Free Cash Flow
PRCT
PRCT
SND
SND
Q1 26
Q4 25
$-12.2M
$20.4M
Q3 25
$-9.5M
$14.8M
Q2 25
$-17.8M
$-7.8M
Q1 25
$-18.8M
$5.2M
Q4 24
$-33.6M
$-840.0K
Q3 24
$-19.0M
$3.7M
Q2 24
$-16.8M
$13.5M
FCF Margin
PRCT
PRCT
SND
SND
Q1 26
Q4 25
-15.9%
23.7%
Q3 25
-11.4%
15.9%
Q2 25
-22.5%
-9.1%
Q1 25
-27.2%
7.9%
Q4 24
-49.2%
-0.9%
Q3 24
-32.6%
5.8%
Q2 24
-31.4%
18.3%
Capex Intensity
PRCT
PRCT
SND
SND
Q1 26
Q4 25
2.4%
2.3%
Q3 25
3.4%
3.6%
Q2 25
3.5%
3.1%
Q1 25
2.7%
5.4%
Q4 24
1.7%
2.1%
Q3 24
0.4%
3.4%
Q2 24
2.0%
1.8%
Cash Conversion
PRCT
PRCT
SND
SND
Q1 26
Q4 25
18.99×
Q3 25
6.05×
Q2 25
-0.24×
Q1 25
Q4 24
0.28×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

SND
SND

Sand$85.1M99%
Smart Systems Segment$980.0K1%

Related Comparisons